Autumn Research Update Meeting 2025
Our 2025 Autumn Research Update Meeting will take place once again at the renowned Royal Society of Medicine (RSM), Wimpole Street, London, on Monday 10 November, where guests can look forward to an engaging agenda featuring the latest updates from our funded research. Theme: Revolutionising...
Learn more
The Australian Parkinson’s Mission
At 9am on the 30th January, 2019, the Australian Government Federal Health Minister Greg Hunt announced the initiation of the ‘Australian Parkinson’s Mission‘ – a very massive $30 million clinical trial programme that will be focused on potentially disease modifying treatments for Parkinson’s. This huge endeavour will being with a large multi-arm study – […]
The Australian Parkinson’s Mission (APM)
The Australian Parkinson’s Mission (APM) – is an international collaboration between the Garvan Institute, Shake It Up Australia Foundation, Parkinson’s Australia, Cure Parkinson’s and the Michael J. Fox Foundation. The collaboration has been awarded a A$30 million government grant to identify and fast-track better treatments…
Exciting Exenatide Exosomes
Recent analysis of blood samples collected during the Phase II clinical trial of Exenatide in Parkinson’s has uncovered a very interesting finding that could have major implications for not only Parkinson’s, but for many different neurological conditions. Exenatide is a treatment that helps to control glucose levels in people with diabetes. More recently, however, […]
Webinar – Targeting the Genetics of Parkinson’s
Presented by the Journal of Parkinson’s Disease, Cure Parkinson’s and Van Andel Institute. In this webinar Professor Patrick Brundin is joined by fellow panellists: Dr Ziv Gan-Or from the Department of Neurology and Neurosurgery at the Montreal Neurological Institute, Benjamin Stecher, co-founder of the Parkinson’s…
Webinar – Does Exenatide reduce Non-motor Symptoms in Parkinson’s?
Presented by the Journal of Parkinson’s Disease, Cure Parkinson’s and Van Andel Institute. Professor Brundin is joined by fellow panelists Professor Tom Foltynie (UCL) who led the recent exenatide trial, Professor Nigel Greig and Dr. Dimitrios Kapogiannis from the National Institute of Ageing (NIA), and…